The ZIKAction Consortium will be presenting preliminary results of its vertical transmission study at the 3rd International Conference on Zika Virus and Aedes related infections that will be held in Washington DC, USA, from 13th to 16th February 2020.
Earlier this month the fourth annual ZIKAction Consortium meeting took place in Guayaquil, Ecuador.
With the 6th issue of the joint ZIKA consortia newsletter we are happy to bring you the latest news about our study on how the project is helping increase the scientific knowledge on the molecular mechanisms behind the trans-placental Zika virus infection.
On 8-9 November the annual ZIKAction Consortium meeting will be held in Guayaquil, Ecuador. Around 40 researchers, health professionals and project managers from partner organizations are planning to participate in the meeting which aims at overviewing the ongoing project studies, their outcomes and setting goals for the upcoming year.
Oct 01, 2019
Knowledge of the molecular mechanisms behind the trans-placental Zika virus infection is one of the most challenging aspects concerning Zika virus congenital disease. Although it is well known that other flaviviruses can occasionally infect the fetus after crossing the placenta, none has the same impact as congenital Zika infection.
We are pleased to bring you the news that ZIKAction partners Fiocruz (Brazil) and University of Oxford (UK) have established a new strategic partnership which will amplify the impact of Fiocruz’s health research and capacity development initiatives by promoting research capacity building across Portuguese-speaking countries, and enabling research findings from the Zika outbreak to benefit public health worldwide.
The 16th International Course on Dengue, Zika and Other Emergent Arboviruses will take place in Havana, Cuba on August 12 – 23, 2019.
In the fifth issue of the joint ZIKA consortia newsletter you can read about the recent developments in the vertical transmission study in Jamaica, sheep as a model of ZIKV infection and the trainings for ZIKAction researchers where novel ZIKV-detecting assays were used.
Four years after the first whistle blow of microcephaly associated with Zika virus infections and science is still scratching its metaphoric head trying to figure out how zika virus works. Though reports of outbreaks have receded since the epidemic of the Americas in 2014-2016, the threat it poses on pregnant women -being an endemic virus- remains severely high.
May 15, 2019
One of the challenges for the consortium has been to identify specific and sensitive zika antibody assays for use in its prospective and retrospective studies. Recently the Diagnostic Development Laboratory of the BNITM (Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany) has developed the BLACKBOX® ZIKV IgG and IgM ELISA Kits
